Virtus Biotech Clinical Trials ETF (BBC)
$40.15-1.21%Close
SELLCRISIS · day 2
Key stats
ETF · income quality metrics
- AUM
- $39M
- Expense
- 0.65%
- Yield
- 1.62%
- Quality
- 29
- Beta
- 1.18
- Max DD
- -76.85%
- 1Y
- +39.64%
- 3Y
- +111.64%
- 5Y
- -7.67%
- 1W
- -7.25%
- 1M
- -17.28%
- vs SPY 1W
- -6.27%
- vs SPY 1M
- -19.15%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BBC?
- LOPJLB’s latest quantitative signal on Virtus Biotech Clinical Trials ETF (BBC) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BBC in?
- Virtus Biotech Clinical Trials ETF (BBC) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Virtus Biotech Clinical Trials ETF (BBC) do?
- This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official nam…